Your browser doesn't support javascript.
loading
In a Rat Model of Opioid Maintenance, the G Protein-Biased Mu Opioid Receptor Agonist TRV130 Decreases Relapse to Oxycodone Seeking and Taking and Prevents Oxycodone-Induced Brain Hypoxia.
Bossert, Jennifer M; Kiyatkin, Eugene A; Korah, Hannah; Hoots, Jennifer K; Afzal, Anum; Perekopskiy, David; Thomas, Shruthi; Fredriksson, Ida; Blough, Bruce E; Negus, S Stevens; Epstein, David H; Shaham, Yavin.
Afiliación
  • Bossert JM; Behavioral Neuroscience Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland. Electronic address: jennifer.bossert@nih.gov.
  • Kiyatkin EA; Behavioral Neuroscience Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland.
  • Korah H; Behavioral Neuroscience Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland.
  • Hoots JK; Behavioral Neuroscience Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland.
  • Afzal A; Behavioral Neuroscience Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland.
  • Perekopskiy D; Behavioral Neuroscience Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland.
  • Thomas S; Behavioral Neuroscience Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland.
  • Fredriksson I; Behavioral Neuroscience Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland.
  • Blough BE; Center for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina.
  • Negus SS; Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia.
  • Epstein DH; Clinical Pharmacology and Therapeutics Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland.
  • Shaham Y; Behavioral Neuroscience Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland.
Biol Psychiatry ; 88(12): 935-944, 2020 12 15.
Article en En | MEDLINE | ID: mdl-32305216

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Oxicodona / Hipoxia Encefálica Idioma: En Revista: Biol Psychiatry Año: 2020 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Oxicodona / Hipoxia Encefálica Idioma: En Revista: Biol Psychiatry Año: 2020 Tipo del documento: Article